STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
BuybackApr 27, 2026, 07:27 AM

NVO Repurchases 13.4M B Shares for DKK 3.44B

AI Summary

Novo Nordisk has repurchased 13,407,992 B shares for DKK 3,438,931,195 as of April 24, 2026, under its DKK 15 billion share repurchase program. This specific tranche aims to repurchase up to DKK 3.8 billion in B shares between February 4 and May 4, 2026. The company now holds 30,797,791 B shares as treasury shares, representing 0.7% of its share capital.

Key Highlights

  • Novo Nordisk's overall share repurchase program is for up to DKK 15 billion over 12 months.
  • The current tranche aims to repurchase up to DKK 3.8 billion in B shares from Feb 4 to May 4, 2026.
  • As of April 24, 2026, 13,407,992 B shares have been repurchased.
  • The total transaction value for repurchased shares is DKK 3,438,931,195.
  • The average purchase price per B share was DKK 256.48.
  • Novo Nordisk now owns 30,797,791 B shares as treasury shares.
  • Treasury shares correspond to 0.7% of the company's share capital.
NVO
Biotechnology: Pharmaceutical Preparations
NOVO NORDISK A S

Price Impact